14158 Results (Page 550 of 567)
All Market Research Reports
Germany Herbal Supplements Market Report
The Germany Herbal Supplements Market was valued at $192.52 Mn in 2023 and is predicted to grow at a CAGR of 4.4% from 2023 to 2030, to $260.24 Mn by 2030. The key drivers of this industry include the prevalence of chronic health conditions, increasing health consciousness, and rising usage of supplements. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, Botanic Supplements, and Bionorica among others.
US Brugada Syndrome Market Analysis
The US Brugada Syndrome Market was valued at $504 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $747.9 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the US Brugada Syndrome Market are Johnson & Johnson, Eli Lilly & Co, AbbVie, Merck & Co Inc, Pfizer, Bristol-Myers Squibb, Amgen Inc, Gilead Sciences, Medtronic, and AstraZeneca, among others.
Saudi Arabia Actinic Keratosis Therapeutic Market Analysis
The Saudi Arabia Actinic Keratosis Therapeutic Market is expected to witness substantial growth, with an estimated increase from $116 Mn in 2022 to $190 Mn by 2030 and a forecasted CAGR projected to be 6.4%. This expected growth is attributed to the intersection of certain factors such as the sun-exposed demographics in Saudi Arabia, increased public awareness of Actinic Keratosis and the ways of treating it, and a growing array of treatment options, including advanced technological solutions and minimally invasive procedures. Key players in the Saudi Arabia Actinic Keratosis Therapeutics Market include Bayer, Galderma, LEO Pharma, Sun Pharmaceuticals, Syneron Candela, Lumenis, Zimmer Biomet, among others
Brazil Brain Cancer Therapeutics Market Analysis
Brazil Brain Cancer Therapeutics Market valued at $58 Mn in 2022, projected to reach $138 Mn by 2030 with a 11.6% CAGR. The market for brain cancer therapeutics is expected to be driven by the anticipated rise in the incidence of brain cancer, especially glioblastoma multiforme, which would raise the demand for therapeutics. Among the prominent players in the pharmaceutical sector are Pfizer, AstraZeneca, Merck & Co., Siemens, Carestream Health, Eisai Co., Genentech, Bristol-Myers Squibb, Eli Lilly, and Sanofi.
US Clinical Nutrition for Chronic Kidney Diseases Market Analysis
US Clinical Nutrition for Chronic Kidney Diseases Market was valued at $659.40 Mn in 2023 and is predicted to grow at a CAGR of 4.03% from 2023 to 2030, to $869.50 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, growing awareness and diagnosis, advancements in medical research, and the aging population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Spain Herbal Supplements Market Report
The Spain Herbal Supplements Market was valued at $101.52 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $144.76 Mn by 2030. The key drivers of this industry include the aging population, growing health awareness, and lifestyle changes. The industry is primarily dominated by players such as Herbalife, Himalaya, Patanjali, and NOW Foods among others.
Saudi Arabia Brugada Syndrome Market Analysis
The Saudi Arabia Brugada Syndrome Market was valued at $20.4 Mn in 2023 and is predicted to grow at a CAGR of 9.3% from 2023 to 2030, to $38 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the Saudi Arabia Brugada Syndrome Market are Jamjoom Pharma, Baxter, Riyadh Pharma, Sanofi, Novartis, and AstraZeneca, among others.
Singapore Actinic Keratosis Therapeutic Market Analysis
The Singapore Actinic Keratosis Therapeutic Market is expected to grow at a CAGR of 5.5% during the forecast period, rising from $8 Mn in the year 2022 and reaching $13 Mn by the year 2030. Factors contributing to the Singapore Actinic Keratosis Therapeutic Market growth include rising healthcare expenditures, an aging population, changing weather patterns, and patient preferences for convenient and effective treatment modalities. Key players in the Singapore Actinic Keratosis Therapeutic Market include LEO Pharma, Galderma, Sun Pharmaceuticals, Bayer, Alma Lasers, Syneron Candela, Novartis and Bausch Health among others
France Brain Cancer Therapeutics Market
France Brain Cancer Therapeutics Market valued at $63 Mn in 2022, projected to reach $132 Mn by 2030 with a 9.6% CAGR. The anticipated increase in brain cancer cases, particularly glioblastoma multiforme, is expected to be a key factor propelling the demand for brain cancer therapeutics, shaping the overall market landscape. Prominent players in the pharmaceutical sector currently operating are Roche, Merck & Co., Bristol Myers Squibb, Novartis, Pfizer, AstraZeneca, Eli Lilly, Sanofi, Takeda Pharmaceutical, and AbbVie.
Saudi Arabia Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Saudi Arabia Clinical Nutrition for Chronic Kidney Diseases Market was valued at $26.70 Mn in 2023 and is predicted to grow at a CAGR of 7.53% from 2023 to 2030, to $44.40 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
UK Herbal Supplements Market Report
The UK Herbal Supplements Market was valued at $136.76 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $182.40 Mn by 2030. The key drivers of this industry include rising consumer preference, increased supplement consumption, and the prevalence of a sedentary lifestyle. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, NOW Foods, Botanic Supplements, and Dabur among others.
UAE Brugada Syndrome Market Analysis
The UAE Brugada Syndrome Market was valued at $6 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $10.8 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the UAE Brugada Syndrome Market are Julphar, Neopharma, Novartis, Boehringer Ingelheim, and Gulf Scientific Corporation, among others.
South Africa Actinic Keratosis Therapeutic Market Analysis
South Africa Actinic Keratosis Therapeutic Market is expected to expand at a CAGR of 6.13% from $44 Mn in 2022 to $71 Mn by 2030. The South Africa Actinic Keratosis Therapeutic Market is poised for continued growth, driven by rising awareness, technological advancements, and an expanding healthcare sector and addressing access and affordability challenges will be crucial to ensure optimal market growth. Global giants like Galderma, Meda Pharmaceuticals, Merck & Co, Bausch, GlaxoSmithCline, etx coexist with smaller regional firms like Aspen Pharmacare, Adcock Ingram, Biovac, Clinitec etc as major participants in the South Africa, which is constantly changing
Malaysia Brain Cancer Therapeutics Market
Malaysia Brain Cancer Therapeutics Market valued at $4 Mn in 2022, projected to reach $8 Mn by 2030 with a 10.8% CAGR. The expected rise in instances of brain cancer, specifically glioblastoma multiforme, is projected to significantly enhance the demand for therapies aimed at treating brain cancer, thereby influencing the overall structure of the market. Top leading pharmaceutical companies presently operating in the market are Merck & Co, Amgen, Roche, Pfizer, Teva Pharmaceutical, Karyopharm Therapeutics, Novartis, AstraZeneca, Bristol Myers Squibb, and Eli Lilly.
Singapore Constipation Therapeutics Market Analysis
Singapore Constipation Therapeutics Market was valued at $22 Mn in 2022 and is estimated to reach $38 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The global growth of the constipation therapeutics market is driven by factors such as aging, sedentary lifestyles, and unhealthy dietary habits. The increasing elderly population, susceptible to chronic conditions, notably contributes to this expansion. Major players in this sector comprise GlaxoSmithKline, Johnson & Johnson, Sanofi, Abbott, Bayer, AstraZeneca, Pfizer, Merck Sharp & Dohme, Boehringer Ingelheim, and United Laboratories.
UAE Clinical Nutrition for Chronic Kidney Diseases Market Analysis
UAE Clinical Nutrition for Chronic Kidney Diseases Market was valued at $7.80 Mn in 2023 and is predicted to grow at a CAGR of 7.03% from 2023 to 2030, to $12.60 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, growing awareness and diagnosis, advancements in medical research, and the aging population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
China Herbal Supplements Market Report
The China Herbal Supplements Market was valued at $422.84 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $710.69 Mn by 2030. The key drivers of this industry include traditional medicine influence, health and wellness trends, and an aging population. The industry is primarily dominated by players such as Ningbo Herb, KPC Herbs, Herbalife, and Kangmei Pharmaceutical Co., Ltd among others.
Brazil Brugada Syndrome Market Analysis
The Brazil Brugada Syndrome Market was valued at $30 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $54.1 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the Brazil Brugada Syndrome Market are Eurofarma, EMS Pharma, Sanofi, Novo Nordisk, and Novartis, among others.
Mexico Brain Cancer Therapeutics Market
Mexico Brain Cancer Therapeutics Market valued at $35 Mn in 2022, projected to reach $79 Mn by 2030 with a 10.85% CAGR. The demand for brain cancer therapeutics is projected to be fuelled by the expected increase in the occurrence of brain cancer, particularly glioblastoma multiforme. This surge in demand for therapeutic interventions is likely to shape the market landscape. Notable participants in the pharmaceutical sector include Pfizer, AstraZeneca, Merck & Co., Siemens, Carestream Health, Eisai Co., Genentech, Bristol-Myers Squibb, Eli Lilly, and Sanofi.
South Africa Constipation Therapeutics Market Analysis
South Africa Constipation Therapeutics Market was valued at $118 Mn in 2022 and is estimated to reach $215 Mn in 2030, exhibiting a CAGR of 7.73% during the forecast period. The constipation therapeutics market is experiencing worldwide expansion due to factors like aging, sedentary lifestyles, and poor dietary habits. The growing elderly demographic, prone to chronic conditions, plays a significant role in driving this growth. Key players in this industry include AstraZeneca, Bayer AG, Sanofi, Sucampo Pharmaceuticals, Takeda Pharmaceutical, Synergy Pharmaceuticals, Ironwood Pharmaceuticals, Salix Pharmaceuticals, Abbott Laboratories and Cosmo Pharmaceuticals NV.
Brazil Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Brazil Clinical Nutrition for Chronic Kidney Diseases Market was valued at $39.20 Mn in 2023 and is predicted to grow at a CAGR of 7.03% from 2023 to 2030, to $63.10 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Indonesia Herbal Supplements Market Report
The Indonesia Herbal Supplements Market was valued at $31.56 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $48.08 Mn by 2030. The key drivers of this industry include a younger population, cultural acceptance, and rising awareness. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife Nutrition, Sido Muncul, and Deltomed Laboratories among others.
Mexico Brugada Syndrome Market Analysis
The Mexico Brugada Syndrome Market was valued at $18 Mn in 2023 and is predicted to grow at a CAGR of 8.05% from 2023 to 2030, to $30.9 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, geriatric population, and advancements in genetic testing. The prominent players of the Mexico Brugada Syndrome Market are Bayer, Roche, Teva, Medtronic, Abbott Laboratories, and Sanofi, among others.
UK Actinic Keratosis Therapeutic Market Analysis
The UK Actinic Keratosis Therapeutic Market is predicted to develop at a CAGR of 2.9%, increasing from $177 Mn in the year 2022 to $222 Mn by the year 2030. The UK Actinic Keratosis Therapeutic Market is expected to grow at a faster rate during the forecast period, owing to a large patient population, increased awareness about the prevention and treatment of Actinic Keratosis, and advancements in medical technology leading to the development of innovative and minimally invasive procedures. Some domestic firms, such as GlaxoSmithKline and Scancell, as well as international Sun Pharmaceuticals, Biofrontera, Nestle, Bausch Health, etc are key competitors in the industry
Indonesia Brain Cancer Therapeutics Market
Indonesia Brain Cancer Therapeutics Market valued at $14 Mn in 2022, projected to reach $31 Mn by 2030 with a 10.6% CAGR. The anticipated increase in cases of brain cancer, particularly glioblastoma multiforme, is expected to markedly boost the need for brain cancer therapeutics, shaping the overall market landscape significantly. The top leading pharmaceutical companies currently operating in the market are Roche, Novartis, Pfizer, Merck, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Sanofi, Johnson & Johnson and Takeda.
